期刊文献+

凝血因子Ⅶ研究进展

原文传递
导出
摘要 人体血浆凝血因子Ⅶ按分子结构和生物活性可分为两种:以酶原形式存在的因子(FⅦ)和以活化形式存在的因子(FⅦa)。FⅦa作为凝血级联反应的起始酶,在正常生理性与治疗性止血中发挥重要作用,并且与多种出、凝血疾病的发生和进程有关,因而日益受到重视。本文就 FⅦ的生物学功能以及重组活化 FⅦ(rFⅦa)的临床应用等方面的研究进展作一综述。
出处 《国际生物制品学杂志》 CAS 2007年第6期274-278,共5页 International Journal of Biologicals
  • 相关文献

参考文献24

  • 1Bach R, Nemerson Y, Konlgsberg W. Purification and characterization of bovine tissue factor. J Biol Chem, 1981,256( 16): 8324-8331.
  • 2Broze GJ, Leykam JE, Schwartz BD, et al. Purification of human brain tissue factor. J Biol Chem, 1985, 260 (20) : 10917- 10920.
  • 3Bach R,Gentry R, Nemerson Y. Factor Ⅶ binding to tissue factor in reconstituted phospholipid vesicles:induction of cooperativity by phosphatidylserine. Biochemistry, 1986, 25 (14): 4007-4020.
  • 4Nemerson Y,Repke D. Tissue factor accelerates the activation of coagulation factor Ⅶ:the role of a bifunctional coagulation cofactor. Thromb Res, 1985,40 (3) : 351-358.
  • 5Rao LV, Rapaport SI. Activation of factor Ⅶ bound to tissue factor:a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA, 1988, 85 (18) : 6687- 6691.
  • 6Suttie JW. Vitamin K-dependent carboxylase. Annu Rev Biochem, 1985,54 : 459-477.
  • 7Pike AC, Brzozowski AM, Roberts SM, et al. Structure of human factor Ⅶa and its implications for the triggering of blood coagulation. Proc Natl Acad Sci USA, 1999, 96 ( 16 ) : 8925- 8930.
  • 8Seetharam S, Murphy K, Atkins C, et al. Cloning and expression of rat coagulation factor Ⅶ. Thromb Res, 2003,109 (4): 225-231.
  • 9Eigenbrot C. Structure, function, and activation of coagulation factor Ⅶ. Curr Protein Pept Sci,2002,3(3) :287-299.
  • 10Warn-Cramer BJ, Rao LV, Maki SL, et al. Modifications of extrinsic pathway inhibitor(EPI)and factor Xa that affect their ability to interact and to inhibit factor Ⅶa/tissue factor: evidence for a two-step model of inhibition. Thromb Haemost, 1988,60(3) :453-456.

二级参考文献80

  • 1Bernstein DE, Jeffers L, Erhardtsen E, et al. Recombinant factor Ⅶ a corrects prothrombin time in cirrhotic patients :a preliminary study. Gastroenterology, 1997,113:1930.
  • 2Kalicinski P, Kaminski A, Drewniak T, et al. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant factor Ⅶ a .Transplant Proc, 1999,31: 378.
  • 3Gerotzizfas GT, Zercas C, Gavrielidis G, et al. Effective hemostasis with recombinant factor Ⅶ a treatment in two patients with severe thrombocytopenia and life-threatening hemorrage.American of Hemat, 2002,69,219.
  • 4Shapirl AD,Gklchrist GS, Hoots WK, et al. Prospective, randomized trial of two doses of rFⅦ a (Novo Seven) in hemophilia patients with inhibitors undergoing surgery. Thrombo Haemost, 1998,80 : 773.
  • 5Anderson JAM,Cook MK, Ludlam CA. Can factor Ⅶ a alone secure haemostasis in patients with liver cirrhosis? Haemostasis,2000,30(suppl. 1): 178.
  • 6Ejiersen E,Melsen T,Ingerslev J, et al. Recombinant activated factor Ⅶ (rFⅦa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices.Scand J Gastroenterol,2001,36:1081.
  • 7Hendriks HGD, Meijer K, Dewolf ITM, et al . Detection the influence of recombinant factor Ⅶ a on coagulation by thromboelastography in liver transplantation. Blood coagulation and fibrinolysis,2002,13(4): 309.
  • 8Kalicicinnski A, Drewnisk T. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor Ⅶ. Transplant Proc,1999,31:378.
  • 9Gerotziafas GT, Zervas C, Gavrielidis G, et al. Effective hemostasis with rFⅦa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Am J Hematology,2002,69:219.
  • 10Hoffman M, Monroe DM, Robert HR, et al. Activated factor Ⅶ activates factor IX and X on the surface of activated platelets: thought on mechanism of action of high-dose activated factor Ⅶ. Blood Firbol,1998,9(suppl 1) :561.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部